Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 2
2004 2
2005 4
2006 3
2007 5
2008 4
2009 2
2010 2
2011 3
2012 2
2013 6
2014 4
2016 1
2017 2
2018 2
2019 2
2020 2
2021 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Identification of a Promiscuous Epitope Peptide Derived From HSP70.
Matsui H, Hazama S, Tamada K, Udaka K, Irie A, Nishimura Y, Miyakawa T, Doi S, Nakajima M, Kanekiyo S, Tokumitsu Y, Shindo Y, Tomochika S, Yoshida S, Iida M, Suzuki N, Takeda S, Yamamoto S, Yoshino S, Ueno T, Nagano H. Matsui H, et al. Among authors: udaka k. J Immunother. 2019 Sep;42(7):244-250. doi: 10.1097/CJI.0000000000000274. J Immunother. 2019. PMID: 31398179 Free PMC article.
Identification of mouse helper epitopes for WT1-specific CD4+ T cells.
Nakajima H, Nakata J, Imafuku K, Hayashibara H, Isokawa K, Udaka K, Fujiki F, Morimoto S, Hasegawa K, Hosen N, Hashii Y, Nishida S, Tsuboi A, Oka Y, Oji Y, Sogo S, Sugiyama H. Nakajima H, et al. Among authors: udaka k. Cancer Immunol Immunother. 2021 Nov;70(11):3323-3335. doi: 10.1007/s00262-021-03003-5. Epub 2021 Jul 16. Cancer Immunol Immunother. 2021. PMID: 34272593 Free PMC article.
Phase I study of a novel therapeutic vaccine as perioperative treatment for patients with surgically resectable hepatocellular carcinoma: The YCP02 trial.
Nakajima M, Hazama S, Tokumitsu Y, Shindo Y, Matsui H, Matsukuma S, Nakagami Y, Tamada K, Udaka K, Sakamoto M, Saito A, Kouki Y, Uematsu T, Xu M, Iida M, Tsunedomi R, Suzuki N, Takeda S, Ioka T, Doi S, Nagano H. Nakajima M, et al. Among authors: udaka k. Hepatol Res. 2023 Jul;53(7):649-660. doi: 10.1111/hepr.13900. Epub 2023 Mar 30. Hepatol Res. 2023. PMID: 36929310
Knockout of the interleukin-36 receptor protects against renal ischemia-reperfusion injury by reduction of proinflammatory cytokines.
Nishikawa H, Taniguchi Y, Matsumoto T, Arima N, Masaki M, Shimamura Y, Inoue K, Horino T, Fujimoto S, Ohko K, Komatsu T, Udaka K, Sano S, Terada Y. Nishikawa H, et al. Among authors: udaka k. Kidney Int. 2018 Mar;93(3):599-614. doi: 10.1016/j.kint.2017.09.017. Epub 2017 Dec 11. Kidney Int. 2018. PMID: 29241623 Free article.
49 results